title: Higher postdexamethasone serum cortisol levels in agoraphobic than in nonagoraphobic panic disorder patients.
abstract: The dexamethasone suppression test (DST) was performed in panic disorder (PD) patients with (n = 32) or without (n = 31) agoraphobia and in normal controls (n = 49). Postdexamethasone serum cortisol levels were significantly higher in agoraphobic PD patients (105.3 +/- 19.3 nmol/L) both when compared to PD patients without agoraphobia (47.3 +/- 7.7 nmol/L; p less than 0.01) and when compared to healthy controls (51.7 +/- 8.3 nmol/L; p less than 0.01). The rate of nonsuppressors (i.e., subjects displaying postdexamethasone cortisol levels greater than 138 nmol/L) was 28% and 3% in agoraphobic and nonagoraphobic PD patients, respectively, and 12% in controls. In patients, the postdexamethasone cortisol levels did not correlate with the number of panic attacks per week, baseline anxiety as measured using the Hamilton Anxiety Scale, depressive symptoms as measured using the Montgomery-Asberg Depression scale, or duration of illness. Data from eight patients in whom a second DST was performed after treatment with imipramine or clomipramine for three months indicate that a marked reduction of the number of anxiety attacks is not necessarily accompanied by a normalization of a pathological DST. In conclusion, it is suggested that the elevated postdexamethasone cortisol levels sometimes observed in agoraphobic PD patients are more closely related to the agoraphobic behavior than to the panic attacks per se.
authors.affiliation: Department of Psychiatry/Neurochemistry, University of Göteborg, Sweden.
authors.forename: P
authors.initials: P
authors.lastname: Westberg
authors.forename: K
authors.initials: K
authors.lastname: Modigh
authors.forename: P
authors.initials: P
authors.lastname: Lisjö
authors.forename: E
authors.initials: E
authors.lastname: Eriksson
mesh_terms: D000328:Adult; D000379:Agoraphobia / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000523:psychology; D002997:Clomipramine / Q000627:therapeutic use; D003907:Dexamethasone; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D016584:Panic Disorder / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000523:psychology; D011569:Psychiatric Status Rating Scales
chemical_list: D003907:Dexamethasone; D002997:Clomipramine; D007099:Imipramine; D006854:Hydrocortisone